BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• BioCapital

  2019 National Math Festival Heads to D.C. on May 4th to Prove Math is Fun and for Everyone

  The schedule is set for the 2019 National Math Festival: a day of hands-on activities, fascinating speakers, and inspiring performances, showcasing how math is everywhere and full of surprises.

  February 6, 2019

   · 

  3 min read
• Pharm Country

  Perlmutter Cancer Center Earns Comprehensive Status from the National Cancer Institute

  Laura and Isaac Perlmutter Cancer Center at NYU Langone Health has been designated a Comprehensive Cancer Center by the National Cancer Institute (NCI), the nation’s authority in cancer research and support.

  February 6, 2019

   · 

  3 min read
• Biotech Beach

  OFC 2019 to Showcase Optical Innovations in Data Center Networks for Key Business Areas

  As data center traffic grows exponentially from cloud computing and applications including Artificial Intelligence (AI), data science and Internet of Things (IoT), the data center landscape is changing rapidly.

  February 6, 2019

   · 

  4 min read
• FDA

  FDA approves Cablivi® (caplacizumab-yhdp), the first Nanobody®-based medicine, for adults with acquired thrombotic thrombocytopenic purpura (aTTP)

  The U.S. Food and Drug Administration (FDA) has approved Cablivi® (caplacizumab-yhdp) in combination with plasma exchange and immunosuppression for the treatment of acquired thrombotic thrombocytopenic purpura (aTTP) in adults.

  February 6, 2019

   · 

  9 min read
• Biotech Bay

  Arterys Named to the 2019 CB Insights AI 100 List

  Arterys, the leader in intelligent, cloud-based medical image analysis software, today announced that it has been named for the second consecutive year to CB Insights’ coveted AI 100 ranking, which showcases the 100 most promising private artificial intelligence (AI) companies in the world.

  February 6, 2019

   · 

  3 min read
• Global Chronic Obstructive Pulmonary Disease Drugs Market Will Grow at a CAGR of 4% During 2019-2023| Technavio

  Technavio has announced the release of their research report on the global chronic obstructive pulmonary disease drugs market for the forecast period 2019-2023.

  February 6, 2019

   · 

  4 min read
• Drug Development

  Medicenna Shows Promising Pre-Clinical Results in Solid Tumor Models with its IL-2 Superkine, MDNA109

  Magnified IL-2 affinity towards CD122 potently synergizes with checkpoint inhibitors

  February 6, 2019

   · 

  6 min read
• Deals

  Australis Capital Commences Trading on the OTCQB Market in the United States

  Australis Capital Inc. is pleased to announce that the Company’s common shares have commenced trading on the OTCQB® Venture Market under the ticker symbol “AUSAF”.

  February 6, 2019

   · 

  4 min read
• Business

  Henry Schein to Webcast Fourth Quarter and Full-Year 2018 Conference Call on Wednesday, February 20, 2019 at 10:00 a.m. Eastern Time

  Henry Schein, Inc. announced that it will release its fourth quarter and full-year 2018 financial results before the stock market opens on Wednesday, February 20, 2019, and will provide a live webcast of its earnings conference call on the same day beginning at 10:00 a.m. Eastern time

  February 6, 2019

   · 

  2 min read
• Business

  Myomo Announces CFO Succession

  Myomo Inc. announced that Ralph A. Goldwasser, its Chief Financial Officer, is retiring effective as of February 18, 2019.

  February 6, 2019

   · 

  4 min read